BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gao ZH, Bai DS, Jiang GQ, Jin SJ. Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma. World J Hepatol 2015; 7(1): 40-43 [PMID: 25624995 DOI: 10.4254/wjh.v7.i1.40]
URL: https://www.wjgnet.com/1948-5182/full/v7/i1/40.htm
Number Citing Articles
1
Jung Yeon Lee, Young Hoon Kim, Young Hoon Roh, Kyung Bin Roh, Kwan Woo Kim, Sung Hwa Kang, Yang Hyun Baek, Sung Wook Lee, Sang Young Han, Hee Jin Kwon, Jin Han Cho. Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's viewAnnals of Surgical Treatment and Research 2016; 90(3): 147 doi: 10.4174/astr.2016.90.3.147
2
Zhan-Qi Wei, Yue-Wei Zhang. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefitChinese Medical Journal 2021; 134(19): 2275 doi: 10.1097/CM9.0000000000001767
3
Malkhaz Mizandari, Tamta Azrumelashvili, Natela Paksashvili, Nino Kikodze, Ia Pantsulaia, Nona Janikashvili, Tinatin Chikovani. Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal AblationCase Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/6843121
4
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCCHepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
5
Qiao Zhang, Feng Xia, Ali Mo, Weiming He, Jiazhen Chen, Weiqiao Zhang, Weiqiang Chen. Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.839597
6
Bei-Ge Jiang, Neng Wang, Jian Huang, Yuan Yang, Liang-Liang Sun, Ze-Ya Pan, Wei-Ping Zhou. Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patientsOncotarget 2017; 8(17): 28621 doi: 10.18632/oncotarget.16157
7
Chao Li, Ming-Da Wang, Lun Lu, Han Wu, Jiong-Jie Yu, Wan-Guang Zhang, Timothy M. Pawlik, Yao-Ming Zhang, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Jun Han, Hao Xing, Zhen-Li Li, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysisHepatology International 2019; 13(6): 736 doi: 10.1007/s12072-019-09981-0
8
Janett Fischer, Stella Wellhöner, Sebastian Ebel, Thomas Lincke, Albrecht Böhlig, Florian Gerhardt, Rhea Veelken, Holger Goessmann, Karen Geva Steinhoff, Timm Denecke, Osama Sabri, Thomas Berg, Florian van Bömmel. The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial TreatmentCancers 2022; 14(21): 5323 doi: 10.3390/cancers14215323
9
Nicholas Fidelman, Robert K. Kerlan. Transarterial Chemoembolization and 90Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage DiseaseAmerican Journal of Roentgenology 2015; 205(4): 742 doi: 10.2214/AJR.15.14802
10
Lizhi Xiao, Enhua Xiao. Blood oxygen level–dependent functional magnetic resonance imaging can evaluate the efficiency of transcatheter arterial chemoembolization in hepatocellular carcinomaJournal of Interventional Medicine 2019; 2(1): 5 doi: 10.1016/j.jimed.2019.05.002
11
Zhen Kang, Enhua Xiao. Expression of cluster of differentiation 151 prior to and following transcatheter arterial chemoembolization therapy in patients with hepatocellular carcinoma and its association with clinicopathological characteristicsOncology Letters 2017;  doi: 10.3892/ol.2017.7371
12
Shizheng Mi, Yang Nie, Changming Xie. Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysisScandinavian Journal of Gastroenterology 2022; 57(9): 1070 doi: 10.1080/00365521.2022.2057198
13
Chunhui Zhou, Zhen Chen, Changli Peng, Changyong Chen, Haiping Li. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18ACancer Biotherapy and Radiopharmaceuticals 2021; 36(2): 211 doi: 10.1089/cbr.2019.3271
14
Xiaofeng Zhang, Jun Li, Feng Shen, Wan Yee Lau. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2018; 33(2): 347 doi: 10.1111/jgh.13843
15
Malkhaz Mizandari, Tamta Azrumelashvili, Nino Toria, Nino Nanava, Ia Pantsulaia, Nino Kikodze, Nona Janikashvili, Tinatin Chikovani. Cured giant hepatocellular carcinoma after transarterial embolization complicated with liver abscess formationRadiology Case Reports 2020; 15(9): 1485 doi: 10.1016/j.radcr.2020.06.008
16
Gerd Otto. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resectionHepatobiliary & Pancreatic Diseases International 2016; 15(2): 122 doi: 10.1016/S1499-3872(16)60071-1
17
N. Venkatanarasimha, A. Gogna, K.T.A. Tong, K. Damodharan, P.K.H. Chow, R.H.G. Lo, S. Chandramohan. Radioembolisation of hepatocellular carcinoma: a primerClinical Radiology 2017; 72(12): 1002 doi: 10.1016/j.crad.2017.07.021
18
Xin Liu, Haodong Li, Fei Wang, Ke Su, Bingsheng He, Jie He, Jiaqi Zhong, Yunwei Han, Zhenjiang Li. Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysisBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02886-1
19
Muhammad Kamran, Aimun Raees, Wasim Jafri. Updates on the Diagnosis and Management of Hepatocellular CarcinomaEuroasian Journal of Hepato-Gastroenterology 2021; 11(1): 32 doi: 10.5005/jp-journals-10018-1335